Heartbeam (NASDAQ:BEAT) is a pioneering company focused on revolutionizing the management of heart disease through its innovative technology. Specializing in the development of advanced electrocardiogram (ECG) solutions, Heartbeam aims to make significant strides in detecting and monitoring heart conditions in a more accurate and efficient manner. Their projects are geared towards leveraging telemedicine and mobile health applications, aiming to provide patients and healthcare providers with critical, real-time cardiac data. Heartbeam's objective is centered around improving patient outcomes and reducing healthcare costs by facilitating early detection of heart issues, thus paving the way for prompt and effective treatment. With its commitment to innovation, Heartbeam is dedicated to leading the charge in transforming cardiac care for people around the globe.